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Abstract 
Background: Rapid diagnostic Tests (RDTs) for malaria enable diagnostic testing at primary care facilities in resource-
limited settings, where weak infrastructure limits the use of microscopy. In 2010, Ghana adopted a test-before-treat 
guideline for malaria, with RDT use promoted to facilitate diagnosis. Yet healthcare practitioners still treat febrile 
patients without testing, or despite negative malaria test results. Few studies have explored RDT implementation 
beyond the notions of provider or patient acceptability. The aim of this study was to identify the factors directly influ-
encing malaria RDT implementation at primary care facilities in a Ghanaian district.
Methods: Qualitative interviews, focus groups and direct observations were conducted with 50 providers at six 
purposively selected primary care facilities in the Atwima–Nwabiagya district. Data were analysed thematically.
Results: RDT implementation was hampered by: (1) healthcare delivery constraints (weak supply chain, limited qual-
ity assurance and control, inadequate guideline emphasis, staffing limitations); (2) provider perceptions (entrenched 
case-management paradigms, limited preparedness for change); (3) social dynamics of care delivery (expected norms 
of provider-patient interaction, test affordability); and (4) limited provider engagement in policy processes leading to 
fragmented implementation of health sector reform.
Conclusion: Limited health system capacity, socio-economic, political, and historical factors hampered malaria RDT 
implementation at primary care facilities in the study district. For effective RDT implementation providers must be: (1) 
adequately enabled through efficient allocation and management of essential healthcare commodities; (2) appropri-
ately empowered with the requisite knowledge and skill through ongoing, effective professional development; and 
(3) actively engaged in policy dialogue to demystify socio-political misconceptions that hinder health sector reform 
policies from improving care delivery. Clear, consistent guideline emphasis, with complementary action to address 
deep-rooted provider concerns will build their confidence in, and promote uptake of recommended policies, prac-
tices, and technology for diagnosing malaria.
Keywords: Rapid diagnostic tests (RDTs), Malaria, Guideline compliance, Primary care, Healthcare provider, Health 
system, Ghana
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Background
The World Health Organization (WHO) estimates about 
214 million cases of malaria occurred worldwide in 2015, 
leading to 438,000 deaths [1]. Other experts argue that 
these reports underestimate the actual burden [2]. Almost 
90 % of the disease burden occurs in sub-Saharan Africa, 
where young children below 5  years of age account for 
more than 78 % of global malaria deaths [3]. Early diagno-
sis and effective treatment within the first 24 h of symptom 
onset are vital to prevent complications leading to death 




*Correspondence:  yanow@ualberta.ca 
7 Alberta Provincial Laboratory for Public Health, Edmonton, Canada
Full list of author information is available at the end of the article
Page 2 of 12Boadu et al. Malar J  (2016) 15:126 
The complete clinical presentation of malaria is highly 
variable, making it poorly distinguishable from several 
other febrile illnesses [5, 6]. Quality-assured microscopy, 
considered the gold standard for diagnosing malaria, is 
also difficult to sustain in resource-constrained environ-
ments [7]. For decades, febrile illnesses in settings includ-
ing Ghana have been treated presumptively as malaria. 
This practice enabled prompt delivery of life-saving 
treatment to reduce mortality especially among chil-
dren under 5 years of age [8]. However, wide availability 
of mostly inexpensive anti-malarials led to rampant pre-
sumptive diagnosis (and misdiagnosis) of most fevers as 
malaria, and inappropriate anti-malarial consumption [9, 
10]. Indiscriminate anti-malarial use, including incom-
plete dosing for repeated malarial infections, is prevalent 
in high transmission areas [9, 11]. This fosters the emer-
gence and spread of drug resistance [12], exacerbates a 
vicious cycle of illness and household poverty, and drains 
limited national and donor resources [13].
The WHO recommends diagnostic testing to confirm 
malaria before providing anti-malarial treatment to sus-
pected cases [4]. This recommendation aims to limit 
indiscriminate anti-malarial use, and is premised on three 
factors: (1) emerging parasitic resistance to anti-malari-
als; (2) declining malaria transmission in previously high 
transmission areas; and (3) increased availability of diag-
nostics, notably, rapid diagnostic tests (RDTs) for malaria 
in resource-limited environments [14]. RDTs do not 
require much infrastructure or technical expertise, fur-
ther questioning the rationale for presumptive treatment 
in the absence of microscopy [8, 15]. Yet RDT implemen-
tation in Ghana and other sub-Saharan African coun-
tries remains low. Optimizing RDT use in these settings 
is vital to expand diagnostic coverage for malaria, while 
ensuring rational use of anti-malarials [16–18].
Malaria transmission in Ghana is endemic and mostly 
uninterrupted, with peaks in the rainy seasons. The entire 
population of over 24 million is at risk of infection year-
round [19]. Over three million cases were reported in 
2013, accounting for 38 % of all outpatient illnesses and 
36  % of hospital admissions. Malaria is also the leading 
cause of morbidity and mortality among children under 
5 years of age, among whom the disease accounted for a 
third of all deaths in 2013 [20].
Despite adopting the WHO’s test-before-treat recom-
mendation for malaria as national policy in 2009, pre-
sumptive treatment practices are widespread across the 
country. Fewer than 33  % of suspected malaria cases in 
Ghana were confirmed through parasitological diagno-
sis in 2013. Rural access to malaria diagnostics remains 
relatively poor, though these areas bear a dispropor-
tionate share of the disease burden [14, 21]. Moreover, 
where RDTs are used, studies conducted prior to national 
adoption of the test-before-treat approach found up to 
45 % of RDT-negative patients in a Ghanaian setting still 
received anti-malarial treatment [16, 17]. Evidence from 
other endemic sub-Saharan African settings suggests 
between 10 and 80  % of malaria-negative patients are 
prescribed anti-malarials [22]. This indicates variable and 
often poor providers’ compliance with the test-before-
treat guideline.
Little is known about the factors directly influencing 
RDT use during routine malaria testing at primary care 
facilities in endemic settings. The main objective of this 
study was to determine which factors influenced RDT 
implementation for routine malaria management at pri-
mary care facilities in the study district.
Methods
This study reports descriptive findings from observa-
tions, qualitative interviews and focus groups discus-
sions conducted with 50 primary care providers in the 
Atwima–Nwabiagya district to elicit their perspectives 
on RDT use and implementation at their facilities. This 
data collection formed part of a focused ethnography to 
identify the determinants of providers’ compliance with 
the test-before-treat guideline for malaria in the study 
district. The overall study was guided by a conceptual 
model that supported the exploration of guideline com-
pliance among primary care providers in the study dis-
trict. The detailed methodology was published separately 
[23].
Based on studies of RDT use in similar settings [24–
28] and Ghana’s National Malaria Control Programme 
(NMCP) strategic plan [29], guideline compliance in this 
study was defined as a two-part commitment from the 
healthcare provider: (1) to test a patient suspected of hav-
ing malaria using a RDT (or microscopy where available); 
and (2) to subsequently manage the case in a manner 
consistent with the test result.
The conceptual model
The conceptual model (Fig.  1) was informed by the lit-
erature on RDT acceptance and use among providers in 
sub-Saharan African settings [17, 24, 30, 31]. Three key 
interactions can be identified involving providers and 
RDTs that affect providers’ compliance with the test-
before-treat guideline for malaria. Interactions between: 
(1) providers and RDTs, expected to affect perceptions of 
utility, suitability and effectiveness [17, 24, 31]; (2) pro-
viders and the policy guideline, considered to influence 
knowledge, understanding, and application of recom-
mendations for malaria management [32, 33]; and (3) 
providers and patients—the hub of technology (RDT), 
policy (test-before-treat) and practice (case management) 
for malaria, where guideline compliance is demonstrable 
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[34–36]. Moreover, the context of primary care delivery 
in the setting was expected to influence these interac-
tions [37].
Sampling and recruitment
The district was selected in consultation with a paedia-
trician specialist (DA) with extensive research experi-
ence in the study area. Malaria was the leading cause of 
morbidity in the district, with 160,000 reported cases 
in 2011. Over 40  % of hospital admissions, and 60  % of 
all-cause mortality among children below 5 years of age 
in 2011 were attributable to malaria [38]. The Ghana 
health service (GHS) operated five of the 17 primary 
healthcare facilities, including four health centres and 
the district hospital. The remaining 12, including three 
hospitals, three health centres, one clinic, and five mater-
nity homes, were private, for-profit facilities. Six facilities 
were purposively selected for provider representative-
ness, through consultations with a study advisory group, 
comprising community leaders and key informants 
familiar with health-seeking patterns in the district. The 
sample included three pairs of complementary govern-
ment and private facilities providing services at commu-
nity, sub-district and district levels respectively (Table 1). 
Health facility (HF) 1, the smallest, was a private mater-
nity home. The nurse midwife in charge was the main 
prescriber responsible for clinical decision-making. The 
private (HF3) and government (HF6) hospitals each had 
one medical doctor who prescribed together with nurses 
and at HF 6 with physician assistants. After initial dis-
cussions with the district health directorate and heads 
of selected facilities, 50 providers (Table 2) were directly 
approached on site to discuss the study and invited to 
participate, with written consent. 
Data collection and analysis
Field research was conducted in the study district from 
November 2011 through October 2012.
Fig. 1 Conceptual framework for investigating healthcare providers’ compliance with the test-before-treat guideline for malaria in a Ghanaian dis-
trict. The four outer boxes in green—historical, health system factors, socio-economic factors, and political factors—represent the broader constructs 
that characterize the context of primary care delivery in the study setting. These contextual factors mediate the processes of RDT uptake for malaria 
management within that context, and invariably influence providers’ compliance with the test-before-treat guideline for malaria. The four inner 
boxes in blue indicate the key interactions that directly influence RDT implementation at primary care settings. The double-headed arrows indicate 
bi-directional influence among these components
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Table 2 Characteristics of included providers per data collection method at each facility
Study facility Facility type Data collection method(s)
(number held, if applicable)
Participating provider cadre(s)
(number per data collection 
method)
Total number of participating 
providers per included study 
facility








Informal interviews (3) Nurse mid-wife (1)
Healthcare assistants (2)












Informal interview (2) Medical officer (1)
Biostatistician/records officer/test- 
ing officer (2)











Informal interviews (5) Medical doctor (1)
Nurse (1)
Lab persons (1)
In-depth, semi-structured interview (1) Health facility administrator









Health care assistants (1)
6
Informal interviews (3) Physician assistant (1)
Laboratory personnel (2)
In-depth, semi-structured interview (2) Physician assistant (2)





3 h × 5 days = 15 h
Physician Assistant (2)
Laboratory Personnel (2)
Health extension worker (2)
11
Informal interviews (3) Physician assistant (1)
Laboratory personnel (2)
In-depth, semi-structured interview (4) Physician assistant (1)
Nurse (prescriber) (2)
Focus group discussion (1) Physician assistant (2)
Enrolled nurse superintendent (1)
Nurse/midwife (1)
Health care assistant (1)
Dispensing technician (1)
HF 6 Non-participant observation









Informal interviews (5) Medical doctor (1)
Nurse manager (1)
Laboratory personnel (3)
In-depth, semi-structured interview (4) Medical doctor (1)
Nurse manager (1)
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Direct observation
Participating providers were observed for one  week at 
their facilities during daily clinical encounters with sus-
pected malaria patients. Observations lasted 2–3 h a day 
at smaller facilities, and 5–8  h at larger facilities with 
longer periods of steady clinic attendance. In accord-
ance with standard methodology, activities of interest 
were noted during observations [39], such as providers’ 
requests for RDTs and their reactions to negative test 
results. Where necessary, informal interviews helped 
clarify observed behaviours [40].
Interviews
Prescribers were interviewed individually, in English, at 
their facilities using a topic guide. Interview questions 
explored providers’ experiences with RDT use, guideline 
knowledge, and perceived challenges or advantages with 
implementing the test-before-treat approach.
Focus group discussions (FGDs)
A total of three focus group discussions (FGDs) were 
conducted at a maternity home, a health centre and 
a hospital, representing each of the included levels of 
care delivery. Sites were selected based on staff sizes 
and availability (Table 2). Two were moderated in Eng-
lish, and the third at a remote facility was moderated 
in the local Akan dialect, to accommodate the partici-
pants’ language preference. This group included a co-
moderator, a public health nurse well known in the 
community, and fluent in Akan. Open-ended questions 
encouraged group interaction, and explored diverse 
perspectives regarding RDTs and the test-before-
treat guideline that were identified during interviews. 
Audio-recordings and handwritten notes were cap-
tured during interviews and FGDs. Digital recordings 
were translated where necessary, transcribed, and tran-
scripts checked for accuracy. Summary notes prepared 
after interviews and FGDs were used to assess topic 
saturation [41]. Transcripts were analysed themati-
cally to address the study objectives using Roper and 
Shapira’s approach [42]. Participants’ responses were 
closely examined to uncover any existing patterns by 
age, gender, facility, or provider type. Participants and 
local advisors were consulted for further clarification of 
responses where necessary.
Ethics
The Health Research Ethics Board at the University of 
Alberta and the Committee for Health Research Publi-
cations and Ethics at the Kwame Nkrumah University of 
Science and Technology in Kumasi approved the study 
protocol. All participants provided individual informed 
consent. Providers also obtained verbal consent from 
patients and assent from caregivers of minors prior to 
observations.
Results
Fifty healthcare providers (HCPs) at six primary care 
facilities in the study district participated in total. There 
were no refusals to participate. Key informants identified 
five health policy and administrative officials at local and 
national institutions (Table 3) whose insights on systemic 
challenges to primary care delivery highlighted contex-
tual factors affecting RDT implementation at national 
and local levels. The main themes identified within the 
data were limited health system capacity, provider per-
ceptions on malaria and its management, provider-
patient interactions, and political factors influencing 
health sector policy reform.
Provider characteristics
Female providers were aged between 21 and 77, and 
males, 31–65  years. Clinical experience ranged from 
17 to 56  years among older providers (≥50  years), to 
3–9 years among providers 21–35 years of age (Table 2).
Health care delivery constraints
Several challenges outlined below hampered RDT imple-
mentation and consequently guideline compliance for 
malaria testing among providers.
Limited RDT supply
Both public and private providers revealed during in-
depth interviews (IDI) and focus group discussions 
(FGD) that RDT supplies from the district health direc-
torate to their facilities were often insufficient and spo-
radic. This challenge was more pronounced at remote 
Table 3 Characteristics of  representative health admin-













Regional Regional Medical Stores 3
Regional Malaria Control 
Office
2





National Health Insurance 
Authority
1
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facilities solely dependent on government supplies, and a 
major hindrance to routine malaria testing at all facilities. 
At the time of the study four facilities had limited RDTs 
while two had none (Table 1). Stock-outs were common, 
sometimes lasting several months, making providers 
hesitant to use limited quantities when available, as illus-
trated in the quotes below:
“… The main problem with this rapid diagnostic test 
kit is the erratic availability…” (HCP, HF6, IDI)
“… As you go deeper in the hinterland, the availabil-
ity of tests also goes down and the rate of blind treat-
ment rises…” (HCP, HF6, IDI)
“… Before we got our current supplies I think we were 
out for almost four months!” (HCP, HF3, IDI)
Malaria testing at public facilities dependent on gov-
ernment RDT supplies was interrupted due to frequent 
and prolonged RDT stock outs. Some private providers 
mentioned purchasing RDTs from independent sources 
when available. Others abandoned RDT use altogether, 
citing the economic and technical advantages of micros-
copy over RDTs, as illustrated below:
“… When… we ask and they don’t have… we sit and 
wait until when they have it. That is the problem.” 
(Government HCP, HF5, IDI)
“… We believe in diagnosis and having the diagnostic 
tools available to do your work and do it well…. all 
our lab technicians are biomedical scientists… why 
would I want to go for RDT?” (Private HCP, HF3 IDI)
“… When I use… microscopy I am just spending 0.10 
GHs per client… for the RDT it’s about GHs 2.00. So 
I would want to go for the cheaper and most efficient 
one.” (Private HCP, HF3, IDI)
Poor RDT storage, distribution, and regulation
Sub-optimal storage, distribution and regulatory mecha-
nisms further limited RDT implementation. Frequently 
delayed distribution and limited storage space at the dis-
trict office meant RDTs were often left outdoors, exposed 
to sunlight and other weather conditions. Providers, con-
cerned with compromised test quality due to poor storage, 
had little confidence in the veracity of test results. Infre-
quent quality assurance and control visits to facilities by 
authorities further undermined providers’ willingness to 
use RDTs. A physician assistant at a health centre stated:
“… What I have observed is that sometimes they 
bring them (RDTs) here and they are left with about 
one month or two months to expire. So they may be 
giving you fake results.” (HCP, HF 4, IDI)
Heavy caseloads
At facilities with microscopy, providers described time 
constraints, as well as limited and costly reagents as fur-
ther barriers to malaria testing. Heavy caseloads resulted 
in long laboratory wait times that precluded test results 
informing clinical decision-making in real-time. Testing 
was often arbitrary, or for detained or admitted patients, 
who often received treatment before results became 
available, as illustrated below:
“You also saw how busy our clinic is… I see about 
150 - 200 patients a day… In Africa I cannot get that 
time… (to test all suspected cases).” (HCP, IDI, HF5)
“… The patient load is barring us from doing RDTs 
in the consulting room. But ideally you should be 
able to do it in the consulting room.” (HCP, HF5, IDI)
Inconsistent guideline information
Guideline reference material including pictorial job aids 
were not widely available at facilities to support RDT use, 
particularly among nurses who often attended to patients 
outside clinic hours. Where available, job aids were not in 
high visibility areas, and apparently, not accompanied by 
the necessary communication to ensure their effective-
ness. One pictorial job aid on RDT use was observed at 
the laboratory at HF 6, the district government hospital. 
A focus group participant here said:
“The first time I saw it (RDT) in a poster on the 
(emergency) ward but I really didn’t know what it 
was.” (FGD participant, HF 6)
Moreover, the NMCP guideline did not recommend 
a specific location for RDT use; neither did it allocate 
primary responsibility for RDT use at the facility level. 
Not surprisingly, there was a lack of consensus and clar-
ity among providers regarding who and where to con-
duct RDTs. RDTs were commonly used at laboratories 
(where available), or at designated sites at the facilities. 
A midwife and a healthcare assistant at HF 1 (a private 
maternity home) tested suspected malaria patients in the 
consulting room. A records officer/receptionist at HF 2, 
a private clinic, conducted RDTs in a designated corner 
of the corridor where patients waited on benches. RDTs 
were commonly referred to as ‘labs’, as were other diag-
nostic tests conducted by trained laboratory staff. Con-
sequently, patients incurred standard laboratory fees 
for RDTs, although the Ministry of Health offered them 
free of charge. Moreover, some providers who routinely 
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prescribed anti-malarials had never conducted a RDT 
on a patient, especially at larger facilities with diversified 
staff roles. This contributed to longer turn around times 




All interviewed providers agreed that the guideline was 
useful to improve malaria management, and equated RDT 
use with guideline implementation. RDTs were considered 
appropriate for basic facilities in remote settings without 
laboratory infrastructure. Providers at hospitals and larger 
health centres with laboratories clearly stated their prefer-
ence for microscopy. Nonetheless, both public and private 
providers prioritized clinical judgment over a malaria test 
result based on malaria prevalence in the setting, risks and 
consequences of delayed treatment as stated below:
“… Looking at the prevalence… the environment 
that we live in … the number of mosquitoes around 
that are biting everybody every time… sometimes 
not treating it and going only by the lab tests… may 
present some problems… in a few (negative) cases… 
I may still go ahead and give… antimalarial think-
ing it’s not going to cause any harm. But if we hadn’t 
treated then probably we may run into complica-
tions of malaria.” (HCP, IDI, HF 2)
Younger providers (≤35 years) echoed the opinions of 
their more experienced colleagues, as captured here:
“… Some of us have been doing the work for so many 
years and if you see and if you take very good his-
tory… you will be able to arrive at the diagnosis.” 
(HCP, 56 years, IDI, government facility)
“… The symptoms… determine what happens. If the 
person complains of a bitter taste in the mouth… you 
have to know that it’s malaria. Even though the test 
result is negative, you have to treat it as malaria… 
the guideline says not to do things that way. But the 
patient’s recovery is really essential.” (HCP, 21 years, 
FGD, private facility)
Gaps in training on RDT use
Most providers reported receiving some training on RDT 
use. Formal training was described as organized work-
shops with incentives including refreshments, travel/
transport per diem allowances, and career develop-
ment credits towards professional licensure, renewal, 
or promotion. Informal training involved peer-to-peer, 
on-site learning without similar incentives. Female pro-
viders were dissatisfied with what they described as 
inadequate in-service training and guideline knowledge, 
which coupled with high staff turn over resulted in few 
suitably qualified staff to support RDT implementation. 
Male providers dismissed these issues as characteristic 
of resource-constrained settings. The quotes below high-
light this difference:
“… Some (providers)… didn’t go for the training 
therefore they don’t know the benefit of doing the 
test… and therefore they are not willing to comply… 
If somebody goes for a workshop… and the person 
comes into educate or teach others, some people don’t 
find it serious to adhere to whatever they are being 
taught by a colleague…” (Female HCP, IDI, HF6)
“…Our place, the staff, they are over hundred. I don’t 
expect everybody to know about RDTs. Even though 
ideally they should know. Not everybody can go 
(for training). But the people who are at the helm of 
affairs, like me who is a prescriber. Like the lab techni-
cians, who deals directly with the RDTs, they are usu-
ally the people they identify… (Male HCP, IDI, HF5)
Insufficient guideline knowledge
Providers were generally aware of the test-before-treat 
guideline for malaria. However, facility heads, staff leads 
and laboratory personnel demonstrated more clarity 
of the underlying rationale than their other colleagues. 
When asked, some nurses, often the first point of contact 
for patients, cited the presumptive treatment approach, 
as shown here:
“… There could be another cause of the signs and 
symptoms that you might mistakenly consider to be 
malaria… to be sure, we should confirm whether a 
suspected case is or is not malaria.” (Facility head, 
HF 4, IDI)
“…When our patients come to the facility…mostly 
it is with fever. So we check for fever… if it’s above 
38  °C, with other signs… sometimes, we decide to 
treat for malaria even if we have not checked… that 
is the guidelines I know…” (Nurse, HF 5, IDI)
NMCP documents recommended using microscopy 
where available, to confirm an inconclusive RDT result. 
Yet a community-level provider highlighted potentially 
inconsistent training messages:
“We attended a workshop on RDTs and we were told 
that medical assistants must have RDTs on hand in 
the consulting rooms. So after the person comes back 
from the lab (microscopy), the medical assistant 
would use the RDT to confirm.” (HCP, FGD, HF 1)
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Provider‑patient interactions
Providers described patients as accepting of RDTs and 
their capacity to aid diagnosis. However, they also said 
patients who tested negative for malaria often asked for 
treatment, preferring not to prolong the symptoms, or 
to face additional costs of further testing. Nonetheless, 
long clinic hours on busy days were a disincentive to rou-
tine malaria testing. Tuesdays were designated market 
days in the study district during which residents engaged 
in livelihood activities earlier in the day. The influx of 
patients after midday contributed to high caseloads and 
prolonged laboratory wait times. Under such pressure, 
providers resorted to presumptive treatment to enable 
timely care delivery.
Within this peri-urban district, the catchment area for 
most facilities included many rural communities. Provid-
ers were well acquainted with conditions in their com-
munities, and unwilling to burden patients with the cost 
of a diagnostic test in addition to potentially inevitable 
treatment costs for malaria. Furthermore, limited RDT 
supplies were insufficient to test every suspected case. 
Presumptive treatment therefore relieved the added pres-
sure of allaying misconceptions of discriminatory case 
management among patients who weren’t tested.
Political influences on health sector reform
Key informants from relevant institutions including 
the national health insurance authority (NHIA), and 
the Society of Private Medical and Dental Practition-
ers (Table 4), threw light on the complexity of perceived 
political influences at the regional level that hampered 
RDT implementation. Health sector reform policies by 
the incumbent government aimed at eliminating coverage 
and reimbursement bottlenecks, fraud, and wastage were 
considered politically instigated punitive measures, and 
unpopular among the general populace. Moreover, most 
providers expressed dissatisfaction with a regional NHIA 
pilot scheme of capitated fee reimbursements. Gov-
ernment reimbursements to providers were frequently 
6–8 months in arrears, prompting providers to apply fees, 
or to refuse service delivery to insured patients. While 
national health insurance coverage included free malaria 
testing using RDTs, other lab tests including microscopy 
were not covered. Given that RDTs were mostly in short 
supply, often conducted in the laboratory, and that reim-
bursements were not forthcoming, insured patients were 
unknowingly charged for them. Providers also preferred 
using microscopy to limit costs to their facilities from 
delayed reimbursements. One prescriber stated: 
“I know they (RDTs) are supposed to be free. But, the 
various heads of institutions that we are under, they’ve 
made it that they (patients) pay.” (HCP, IDI, HF 4)
Discussion
The general consensus among providers that RDTs are 
useful indicates potential endorsement of the shift from 
presumptive to test-based malaria management. None-
theless, the priority given clinical judgment suggests lim-
ited confidence in RDTs. Previous research linked this 
finding to concerns over the safety of withholding treat-
ment from febrile patients [43]. Clear communication 
and consistent emphasis of the test-before-treat guideline 
and its underlying rationale are critical to address deep-
rooted provider concerns and to build confidence in the 
reliability of RDTs. Common complaints of sporadic and 
inadequate RDT supplies imply systemic health resource 
availability and allocation constraints beyond the facil-
ity level. This finding, supported by previous research in 
low-income, malaria-endemic settings [44, 45], highlights 
the critical nature of resource availability and manage-
ment to RDT implementation.
Limited health system capacity often indicates com-
peting development priorities, and reflects the broader 
socio-economic and political contexts of primary care 
delivery in the setting [46]. Given the public health sig-
nificance of malaria locally and nationally, the 1 % district 
budget allocation to its management is inadequate. An 
upward revision should accommodate guideline com-
munication and emphasis, and logistical support for RDT 
distribution, storage and use.
National dissemination efforts may have been some-
what successful, as providers were generally aware of the 
guideline. However, the lack of clarity among non-lead 
and non-laboratory staff suggests gaps in training cov-
erage. Given the multi-factorial influences on training 
message uptake in low- and middle-income countries, 
evidence linking investments in health worker train-
ing on improved health outcomes is sparse [47]. Widely 
used approaches that may help to overcome guideline 
implementation barriers include training, print material 
and self-audit [48, 49]. Socially innovative initiatives that 
employ the seniority and experience of long-serving staff 
may support best practices uptake among new or less 
experienced colleagues. To better support the needed 
paradigm shift, programme and policy officials should 
engage providers in discussing facility-based evidence 
aggregated at district and regional levels. Such discus-
sions can highlight the growing incidence of non-malarial 
febrile illnesses, advantages of RDT-supported diagnosis, 
and anti-malarial resistance development. This will pro-
mote buy-in and can inform behavior change communi-
cation strategies targeting providers.
Female participants’ dissatisfaction with existing train-
ing opportunities suggests potentially gender-related 
inequities with training coverage. This gap may stem 
from socio-cultural norms in Ghanaian society, where 
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males enjoy preferential educational and career advance-
ment opportunities. Societal expectations are that 
females should take a more nurturing role, in and outside 
the home. Most nurses in this study were female, while 
physicians, physician assistants, lead staff, and laboratory 
personnel were generally male (Table 2). Given the socio-
cultural and gendered representation among different 
provider types, planning for in-service training should 
pro-actively accommodate gender- and provider-based 
equality. Rotational training opportunities should target 
nurses, often the first point of contact during and out-
side regular clinic hours. This will mitigate knowledge, 
skill and proficiency gaps that limit RDT implementation. 
As an example, a survey conducted in Sudan found that 
76  % of providers nation-wide had not received train-
ing on RDT use and less than 50 % had ever received any 
training through the Sudanese National Malaria Control 
Programme [50]. The cascade (trainer of trainees) system 
prevalent in low-income settings relies largely on peer-to-
peer knowledge transfer. For this to be effective, periodic 
review using relevant indicators is essential to identify 
and eliminate inefficiencies, and to promote account-
ability. Inadequate staffing levels at peripheral facilities 
in remote sub-Saharan settings imply that healthcare 
personnel routinely provide services beyond their profes-
sional designation, qualification, or job description [44]. 
High staff turnover alluded to by participating providers 
in this study might suggest remaining staff were similarly 
overstretched. Forecasting for high-volume clinic peri-
ods will enable RDT use to facilitate rather than hamper 
timely clinical decision-making for malaria.
Limitations
Data generated from this study were based on interview 
(reported) accounts of experiences with RDT use for 
malaria management. Triangulation involving focus groups 
and direct observations was used to corroborate the infor-
mation, in addition to reviewing relevant government and 
local documents. These included the NMCP, strategic plan 
for malaria control [29], guidelines for malaria manage-
ment and district RDT distribution records. It is possible 
that providers may have behaved differently while being 
observed. However, the rationale for their routine behav-
ior of treating fever patients presumptively was to prevent 
avoidable complications or death. This made it unlikely for 
providers to behave differently while being observed, given 
patients would still face the same risks.
Conclusion
Health system capacity is integral to successful malaria 
RDT implementation. To maximize the potential contri-
bution of RDTs, providers should be equipped with the 
requisite knowledge, skill, and resources to accurately 
diagnose malaria, while accommodating differences 
in capacity and context across primary care settings. 
A number of recommendations to address these gaps 
Table 4 Socio-demographic characteristics of interviewed healthcare providers including heads of facilities (HOFs)
Health facility (HF) Healthcare provider  
qualification
Gender Age  
(years)








Nurse mid-wife (HOF) Female 77 56 16
Healthcare assistant Male 25 4 4










Medical doctor (HOF) Male 35 9 2.5





Physician assistant (HOF) Male 51 14 5





Physician assistant (HOF) Male 56 24 18
Nurse Female 32 9 7





Medical doctor (HOF) Male 51 28 1
Nurse manager Female 55 17 1
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emerge from this work. (1) Strategic resource planning 
should support RDT implementation at basic facilities 
while strengthening laboratory capacity in hospitals. 
(2) Policy makers should enable equitable in-service 
training opportunities, and engage providers in policy 
development for malaria. (3) Policy-practice dialogues 
should consider the multifactorial nature of the desired 
paradigm shift for providers, and address topical issues 
including trends in prevalence of malaria and non-
malarial fevers, and anti-malarial resistance develop-
ment. (4) Experienced providers should mentor junior 
colleagues to reinforce updated clinical standards. (5) 
Peer and patient interactions influencing RDT accept-
ability and use among providers in different primary care 
settings should be assessed to inform behavior change 
communication strategies. Collectively, these actions 
will progressively mediate negative perceptions of RDT 
use and sustain test-based diagnosis of malaria at all lev-
els of primary care.
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